Home > PJ (current issue)> Articles

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7338 p237-239
26 February 2005

This article
Reprint   Photocopy

PDF 130K, Acrobat Reader

Articles

What role will there be for pharmacists in the treatment centre programme?

Treatment centres are changing the way that elective surgery is carried out in the NHS. There are already over 30 centres, mostly carrying out orthopaedic and ophthalmic surgery, and many more are in the planning stage. This article, prepared by Joanna Lumb on behalf of the Royal Pharmaceutical Society’s Hospital Pharmacists Group, outlines the Department of Health’s treatment centre programme and the implications for the pharmacy profession


Waiting list targets

NHS Plan waiting list targets:

· By end of 2005, patients should not wait more than six months for elective surgery (measured from time of diagnosis)

· By end of 2008, patients should not wait more than three months for elective surgery (measured from time of diagnosis)

NHS Improvement Plan waiting list target:

· By 2008, patients should not wait more than 18 weeks from GP referral to elective surgery

Treatment centres are changing the delivery of care for patients requiring elective surgery in England. The centres (previously called diagnostic and treatment centres) were announced in the NHS Plan1 in 2000. They form part of the modernisation agenda and are intended to increase acute capacity and so help to meet the NHS Plan waiting list targets and the tighter target in the NHS Improvement Plan2 (see Panel).

Treatment centres (TCs) are essentially fast-track surgical centres. They are designed for day case or short stay elective surgery. Some also carry out diagnostic procedures, such as endoscopy, ultrasound and echocardiography.

The centres are intended to deliver a high volume of activity in a predefined range of routine treatments and diagnostics to meet local demand. Separating scheduled (elective) surgery from emergency surgery means that cancellation of planned operations because of seasonal demands and emergency cases is unlikely. In theory, too, the availability of a TC will speed up treatment for patients admitted to emergency care by relieving pressure on beds.

The development of treatment centres can be seen as a step towards provision of three levels of care:

· GP-led care (including walk-in centres)
· Treatment centres for uncomplicated elective surgery
· Hospital care, with the availability of an intensive care unit, for more complicated elective surgery and emergency care

Some of the TCs are run by the NHS and some by independent companies (independent sector treatment centres, ISTCs), but all are for NHS patients.

Treatment centres

Treatment centres are essentially fast-track surgical centres

The Department of Health describes TCs as dedicated units offering safe, fast, prebooked day and short-stay surgery and diagnostic procedures in specialties that have traditionally had the longest waiting times, for example, orthopaedics and ophthalmology. Surgery carried out in the centres includes hip and knee replacement, minor orthopaedic surgery, hernia repair and gall bladder and cataract removal.

The DoH says that core objectives of the TC programme are:

· To improve access to acute elective care
· To modernise the way the NHS provides diagnostic and elective care
· To drive productivity gain by stimulating new models of service delivery

The NHS Plan announced that 20 TCs would be developed by 2004. In the event, in December 2004 there were 28 NHS TCs and six ISTCs (offering a full or interim service) in England.3 The latest estimate is that by the end of 2005 there will be 80 TCs: 46 NHS-run centres plus 34 centres run by the independent sector.2

TCs are established (or planned) throughout England, with particular clusters in some areas, including Greater London, Greater Manchester, Cheshire and Merseyside, Birmingham and Hampshire. They provide services across traditional organisational boundaries.

Day surgery constitutes a large proportion of the elective surgery currently taking place in TCs but the TC programme is separate from the Government’s day case programme (which is aiming to encourage more day case surgery, from the current 40 to 50 per cent of all elective surgery to around 75 per cent).

Different models

TCs are run either by the NHS (mainly by acute trusts, but some by primary care trusts) or are commissioned by PCTs from private sector providers.

There is a wide range of different models of TC, dealing with a variety of specialties and funded in a variety of ways. Some are in purpose-built premises, others in existing or refurbished NHS facilities, and some are mobile surgical units. The DoH also describes certain “virtual centres” where, for example, there is no specific centre but a number of units contribute to the elective surgery programme.

There are different referral routes into a TC. For example, in some places a patient is referred to a specialist in the acute hospital who decides whether they will be suitable for the TC (ie, that their surgery is expected to be uncomplicated). Patients may also be transferred to a TC from another hospital’s waiting list and some GPs refer patients direct to the TC — this last referral route might increase from December 2005 when GPs are meant to be giving all patients a choice about where they are treated.2

Eventually, when electronic booking systems are in place, there is likely to be direct GP booking of a place in the TC theatre schedule.

The DoH defines three different types of TC:

· Entirely NHS
· Entirely independent sector
· Joint ventures, which may be either NHS or independent sector led

At present there is only one joint venture. This is the Redwood Centre in Redhill, Surrey, which is managed by BUPA with NHS staff.

At Kidderminster in Worcestershire there will be two TCs — one NHS centre and one ISTC — in the same building (on the site of the Kidderminster Hospital) and using the same facilities but running separately. The ISTC will carry out orthopaedic surgery while the NHS TC includes a primary care centre, a nurse-led minor injuries unit and outpatient clinics as well as elective surgery and diagnostics.

The primary-care led TCs include a centre on the site of the Chase Community Hospital in Bordon, Hampshire, and a centre at Ilkeston Community Hospital in Erewash PCT. The Chase Hospital TC offers preoperative assessment for local patients having day surgery elsewhere, leg ulcer clinics, chronic pain management and some diagnostic services. Ilkeston Hospital TC has day case theatres and diagnostic services.

Newham PCT, in London, has a dermatology TC run by a GP with a specialist interest in dermatology. Patients are referred to the centre by GPs who want a second opinion but do not consider that hospital referral is necessary.

The change in name from “diagnostic and treatment centre” to “treatment centre” does not indicate any change to the TC programme. Trusts are expected to move diagnostic services into the centres although this has not yet happened to any significant extent.

Experience to date

The Modernisation Agency reports that TCs have certainly been successful in achieving their aim of reducing waiting lists. Other benefits are also said to have occurred from innovative ways of working associated with the TCs. For example, length of hospital stay for certain knee surgery has reduced markedly by use of new care pathways and effective discharge planning.

However, in late 2004 it was reported that some NHS TCs are in financial difficulty because of insufficient patient referrals. One suggested explanation is that patients may prefer to wait for local treatment rather than travel (in some cases long distances) to receive earlier treatment in a TC. In some places, it appears that GPs have been reluctant to make referrals to the new centres. Another issue is that some PCTs might have run out of money for new referrals for the current financial year.

Also, although across England there are still long waiting lists, it has been suggested that there might now be too much capacity in some areas.

The Ambulatory Care and Diagnostic Centre (ACAD) at Central Middlesex Hospital, in West London, and Ravenscourt Park, the orthopaedic TC for North West London — seen as flagship TCs — have both reported excess capacity because of insufficient referrals.

ISTCs

Many of the companies that have been awarded contracts to run the ISTCs are not traditional UK private sector providers but are foreign-based companies.

The current ISTCs, which have initial five-year contracts, are largely surgical units although there is a mobile magnetic resonance imaging unit. Procurement of further independent sector diagnostic facilities is under way.

The first ISTC opened in Daventry in 2003, run by the Birkdale Clinic. It is a modular build in the grounds of the Daventry and South Northants PCT headquarters at Danetre Community Hospital. In its first year, the TC concentrated on cataract surgery, and the PCT says that waiting times in Northamptonshire were reduced from nine to three months.

The Government’s plans for ISTCs have proved controversial. Although welcoming the extra capacity and the chance to shorten waiting lists, the British Medical Association, the Royal College of Physicians and the Royal College of Surgeons have all expressed reservations. These include concern that the centres will “poach” NHS staff, that moving uncomplicated surgery out of the acute hospitals will limit training experience for surgeons and that the centres may impact on income flow to local acute NHS hospitals. Another stated concern is that freestanding ISTCs may not be able to cope with unexpected clinical problems.

The DoH response is that it is not possible to increase capacity in the NHS fast enough to meet waiting list targets and that the independent sector units are being approved where there are bottlenecks and the NHS does not have the capacity — in terms of premises, staff or management — to deliver TCs.

Initially, the DoH emphasised that ISTCs would not be allowed to dilute NHS staff resources and that all staff would be additional (and would either come from overseas or would not have worked in the NHS in the previous six months). This was apparently on the understanding that all work in the ISTCs would be additional to NHS work. In the event, some PCTs have transferred work from acute trusts into an ISTC, and in such cases NHS staff are being allowed to transfer to the ISTCs under secondment arrangements.

An illustration of the work patterns is given by the recent announcement of five new ISTCs in the South East that plan to treat 16,000 patients a year — around 6,000 procedures will be new activity while the rest will transfer from the NHS, freeing local NHS facilities.

Pharmacy services

What does the development of TCs mean for pharmacy? Pharmacy services, in addition to supply, that are being provided by some of the early centres include involvement in preoperative assessment clinics, development of protocols for discharge medicines, ward-based pharmaceutical care, setting up patient group directions (PGDs) and support to nursing staff on medicine issues.

A key requirement of TCs, given the rapid patient throughput, is well-organised and effective discharge planning. For pharmacy, this means that procedures are needed to ensure that patients have the drugs they need by the time they are ready to be discharged.

Since the work of a TC is carried out to defined care pathways, it can be helpful for pharmacists to be part of the multidisciplinary team setting up these systems to ensure that appropriate pharmaceutical input is included. Much of the medicine supply, eg, postoperative antibiotics and analgesics, is protocol-driven.

The current NHS TCs have adopted different models of pharmaceutical service provision, depending on funding and staffing issues and on perceived need. Some NHS TCs have had funding for pharmacy services. Others have had no new money and services have had to fit around the existing workload. As a result, some NHS TCs have their own pharmacy staff and offer a full clinical pharmacy service while others are unable to offer more than a medicines supply service to the TC, although pharmacy advice is always available as required.

Although the aim is to select “uncomplicated” patients for surgery in TCs, there are still medication issues to consider and pharmacy involvement in TC preoperative assessment clinics has been instigated in several centres. In these clinics, the pharmacist takes a medication history, sorts out any medicine problems, arranges discharge medicines and can advise on any medicines — prescription, OTC or complementary — that need to be stopped before surgery.

In one NHS TC in which pharmacists were involved in the preassessment clinics (funding for this has now ended), PGDs were used for discharge medicines — mostly analgesics — which were supplied to the ward in advance of the patient’s admission. In a few cases, the discharge medicines were given to patients at the preassessment clinic, although this did cause some problems with patients losing their medicines by the time they were required.

Ravenscourt Park TC, a stand-alone TC in West London, has one full-time pharmacist and an on-site dispensary. Agreement has recently been obtained for the pharmacist to attend preassessment clinics. The pharmacist also carries out ward-based prescription monitoring and medicines management. Discharge medicines are dispensed in advance and kept in the patient’s bedside locker. There is also funding for a technician at Ravenscourt Park but this post is currently unfilled as there is insufficient work.

Another TC with funding to provide a clinical pharmacy service is the Orpington NHS TC. This centre, which occupies one floor of the old Orpington Hospital, has three wards, two of which (44 beds) are currently open for orthopaedic and general surgery. A team of two pharmacists, two technicians and one pharmacy assistant work full time on the TC and are involved with patients from pre-assessment through to discharge. There is no dispensary at the TC at present — one is currently being built — and so medicines are obtained from the nearby acute hospital. The pharmacy staff are currently looking to see if there is any opportunity for supplementary prescribing in the unit.

Even with a high level of pharmacy service, it is unlikely that pharmacists can see all patients because TCs can have long working hours and might, for example, run weekend preassessment clinics. In several centres, pharmacists have therefore been involved in training and in setting up protocols to support nursing staff on medicine issues.

Much of the medicines supply in TCs involves use of prepacks and PGDs for nurse supply. Medicines for which PGDs have been developed by pharmacists, or are planned, include postoperative analgesics, laxatives, eye drops and, in one endoscopy centre, Helicobacter pylori eradication regimens.

Some NHS TCs are physically linked to an acute NHS hospital; others are some distance away, which can be an issue if there is no on-site pharmacist. For example, medicines for the NHS TC at Kidderminster Hospital are supplied from the pharmacy at the Alexandra Hospital in Redditch, around 20 miles away. In this TC, medicines are provided as prepacks with PGD supply by nurses, and on FP10HP prescriptions. Occasionally, prescriptions might be faxed to the pharmacy.

The Central Middlesex Hospital ACAD is only a few hundred yards from the main hospital. Medicine supply for the day surgery patients is again largely via PGDs and prepacks, but a porter service is available to take prescriptions to the main hospital pharmacy for items that the pharmacist would want to check, such as paediatric ear, nose and throat medicines.

The current primary-care led NHS TCs have little day-to-day pharmacy involvement although PCT pharmacists will be involved in policy on medicine issues.

ISTCs have to be registered with the Healthcare Commission, which defines national minimum standards. One of the commission’s guidelines is that TCs should have pharmacy advice. At present, most of the ISTCs do not have their own pharmacies but have contracted with an NHS supplier for pharmacy services.

For some centres, this is an interim arrangement. For example, Care UK Afrox Healthcare, a consortium of Care UK and Afrox Healthcare, a South African company, has two interim ISTC sites for orthopaedic surgery, at Ilkeston Hospital and Bassetlaw Hospital, where there are agreements with the local trusts for pharmacy services. In June, the ISTC will move to a new purpose built, freestanding site at Barlborough Links which will have its own pharmacy. Pharmacy staff will be recruited for this centre — like the medical and nursing staff, pharmacists must have not worked in the NHS in the past six months. There are similar plans for the company’s orthopaedic ISTC in Plymouth.

Two mobile ophthalmic ISTCs (for cataract surgery) are being run by Netcare UK, another South African company. The units park in hospital sites and pharmaceutical services are procured from the host hospital. Netcare is also opening an ISTC in Trafford, Manchester, in 2005. This centre is a new building on the Trafford General Hospital site and it will undertake orthopaedic surgery, general surgery and ear, nose and throat surgery. Pharmacy supply and support services will be provided by the hospital pharmacy under a service level agreement.

For some of the other planned ISTCs, the provider has not yet decided whether to provide an in-house pharmacy service or to contract a service from the local trust.

Conclusion

Treatment centres seem likely to become an established model for providing routine elective surgery in England. They should provide a cost-effective way of treating patients and have already had an impact on waiting lists. Pharmacists need to be aware of this development when planning their future services.

· Community pharmacists need to be prepared for this development as they may be involved in dispensing treatments previously provided by hospitals

· Hospital pharmacists need to have protocols in place to respond to these new ways of working and have an adequate range of pre-packed medicines

· The need for adequate medication histories is crucial to prevent delays in discharge — although hospital pharmacies may obtain these at preadmission clinics, they need to liaise closely with their community pharmacist colleagues

Early experience from the first TCs is of varying levels of pharmacy involvement, from provision of a full clinical service to training of nursing staff on medicine issues. Setting up new ways of medicine supply, such as through PGDs, is also prominent. Since the TCs are designed for rapid patient throughput, a key aspect for pharmacists will be in the development of protocols for postoperative discharge regimens. The treatment centre programme is one example of the evolving patient-centred systems of health care for which all pharmacists will need to be prepared.

ACKNOWLEDGEMENTS Thanks are due to Ray Fitzpatrick and Alison Ewing, chairman and member, respectively, of the Hospital Pharmacists Group Committee.


References

1. Department of Health. NHS plan: a plan for investment, a plan for reform. London: Stationery Office; 2000.
2. Department of Health. The NHS improvement plan: putting people at the heart of public service. London: The Department; 2004.
3. Department of Health. Chief executive’s report to the NHS. London: The Department; 2004.

Back to Top


©The Pharmaceutical Journal